Cardlytics Bundle
Who Really Owns Cardlytics?
Ever wondered who pulls the strings behind the scenes at a company that's reshaping how we see advertising? Cardlytics, the advertising platform leveraging consumer purchase data, has a fascinating ownership story. From its inception in 2008, this company has evolved, attracting a diverse group of stakeholders. Understanding the Cardlytics SWOT Analysis is crucial for investors.
This exploration into Cardlytics ownership will reveal the key players shaping its future. We'll examine the evolution of its ownership structure, from early investors to current major shareholders, offering insights into its strategic direction and financial performance. Knowing "Who owns Cardlytics" is critical for anyone tracking Cardlytics stock, its business model, and the influence of its investors.
Who Founded Cardlytics?
The company, now known as Cardlytics, was founded in 2008. The founders, Scott Grimes and Lynne Laube, aimed to revolutionize marketing using consumer purchase data. Hans Theisen is also listed as a co-founder.
Scott Grimes served as CEO and co-founder, while Lynne Laube was the COO and co-founder. Their initial focus was on leveraging consumer purchase data to provide targeted advertising. The early ownership was primarily held by the founders themselves.
Cardlytics's early success attracted investments from various backers, which played a crucial role in its growth. These early investors acquired stakes in the company's ownership, supporting its expansion and development.
Scott Grimes and Lynne Laube founded the company in 2008. Hans Theisen is also listed as a co-founder. Grimes was the CEO, and Laube was the COO.
The founders aimed to transform marketing. They planned to use consumer purchase data to deliver effective advertising.
Early investors included ITC Holding Co., Kinetic Ventures, Canaan Partners, Polaris Venture Partners, and TTV Capital. Discovery Capital made a major investment in 2011.
At the beginning, the founders held significant stakes. Specific equity splits are not available in public records.
Agreements were in place to manage founder shares and investor stakes. These agreements covered vesting schedules and transfer restrictions.
Early investments fueled the company's expansion. These investments supported innovation efforts.
The initial Cardlytics ownership structure was primarily held by founders Scott Grimes and Lynne Laube. Early investors played a crucial role in the company's growth. Notable early investors included ITC Holding Co., Kinetic Ventures, Canaan Partners, Polaris Venture Partners, and TTV Capital. Further investments from Discovery Capital in 2011 helped expand the company. For more details on the company's strategic direction, consider reading about the Growth Strategy of Cardlytics.
- The founders, Grimes and Laube, had significant initial stakes.
- Early investors provided capital for expansion.
- Investment agreements governed share ownership.
- The company's business model evolved with these investments.
Cardlytics SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Cardlytics’s Ownership Changed Over Time?
The ownership structure of Cardlytics has evolved considerably since its inception. Initially, the company was primarily owned by its founders and early investors. The landscape shifted significantly in 2018 when Cardlytics went public, offering shares on the Nasdaq Global Market under the ticker symbol CDLX. This initial public offering (IPO) opened the door for public investors to become part-owners, broadening the ownership base.
As of early 2025, Cardlytics ownership is a blend of institutional investors, insiders (including founders), and public shareholders. Institutional investors hold a substantial portion of the company's stock, ranging from approximately 25.90% to 43.76%. Insiders maintain a significant stake, holding around 13.06% to 37.99%. Retail investors account for approximately 8.96% to 43.18% of the shares. Key institutional shareholders as of March 31, 2025, include CAS Investment Partners, LLC, BlackRock, Inc., The Vanguard Group Inc., 683 Capital Management, LLC, and KPS Global Asset Management UK Ltd. Notably, Clifford Sosin is the largest individual shareholder, owning 15.16 million shares, which represents 28.87% of the company.
| Shareholder | Shares Held | Percentage of Ownership |
|---|---|---|
| CAS Investment Partners, LLC | 5,613,922 | Data not available |
| BlackRock, Inc. | 3,146,677 | Data not available |
| The Vanguard Group Inc. | 2,668,125 | Data not available |
Several key events have influenced Cardlytics ownership. The acquisition of Bridg in 2021 expanded Cardlytics' capabilities and impacted its ownership structure. In January 2024, Cardlytics resolved disputes related to the Bridg merger by agreeing to pay Shareholder Representative Services LLC (SRS) $25 million in cash and issue 3.6 million shares of Cardlytics stock. These shares were issued in February 2024, with remaining cash payments scheduled for January 2025 ($3 million) and June 2025 ($2 million), further diversifying the shareholder base. To learn more about the company's beginnings, you can read the Brief History of Cardlytics.
Cardlytics' ownership structure is a mix of institutional investors, insiders, and public shareholders.
- Institutional investors hold a significant percentage of the company's stock.
- Insiders, including founders, maintain a considerable stake.
- The IPO in 2018 allowed public investors to become part-owners.
- Key shareholders include CAS Investment Partners, BlackRock, and The Vanguard Group.
Cardlytics PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Cardlytics’s Board?
The Board of Directors is central to the governance and strategic direction of Cardlytics. As a publicly traded entity, Cardlytics prioritizes strong corporate governance to ensure transparency and accountability. The board includes representatives from major shareholders, founders, and independent directors. Information regarding the current board members, their affiliations, and voting power percentages can be found in SEC filings, such as the definitive proxy statement for the annual meeting. Understanding the composition of the board is crucial for investors interested in Cardlytics ownership and its future.
In September 2023, a cooperation agreement between Cardlytics and certain investors led to the appointment of Alex Mishurov to the Board as a Class I director, with a term expiring at the company's 2025 Annual Meeting of Stockholders. This agreement also included voting commitments from the investors to support the Board's nominees and recommendations on most proposals, with some exceptions for significant transactions or differing recommendations from proxy advisory firms. This highlights the influence of major Cardlytics investors on the company's direction.
| Board Member | Title | Notes |
|---|---|---|
| Alex Mishurov | Director | Appointed September 2023, term expiring at the 2025 Annual Meeting. |
| Specific Board Members | Titles and Affiliations | Details available in SEC filings, such as the definitive proxy statement. |
| Other Directors | Titles and Affiliations | Details available in SEC filings, such as the definitive proxy statement. |
Cardlytics' corporate structure, as detailed in past SEC filings, prohibits cumulative voting in director elections. Additionally, board vacancies can only be filled by a majority of the directors in office, even if less than a quorum. These provisions can affect the ability of stockholders to influence the composition of the board and, consequently, the company's strategic decisions. For more information about the target audience of Cardlytics, you can read this article Target Market of Cardlytics.
The Board of Directors oversees Cardlytics' strategic direction and governance, with members representing major shareholders and independent seats. SEC filings provide details on board composition and voting power. Understanding the board's structure is crucial for investors evaluating Cardlytics ownership.
- Board members include representatives from major shareholders and independent directors.
- The company's corporate structure impacts stockholder influence on the board.
- Cooperation agreements with investors can shape board appointments and voting commitments.
- For the latest board member information, refer to SEC filings.
Cardlytics Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Cardlytics’s Ownership Landscape?
Over the past few years, several developments have reshaped the ownership landscape of Cardlytics. In March 2024, the company engaged in equity financing through common stock issuance, using the proceeds to support strategic debt repurchases. Simultaneously, Cardlytics entered an equity distribution agreement to sell up to $50 million of common stock via sales agents. These moves indicate efforts to manage capital structure and potentially attract new Cardlytics investors.
Further impacting Cardlytics ownership, the company priced a $150 million convertible senior notes offering in March 2024. Approximately $169.3 million of the proceeds and cash on hand were allocated to repurchase $183.9 million of its 1.00% convertible senior notes due 2025. Leadership changes have also influenced the company; for instance, Karim Temsamani stepped down as CEO in August 2024.
| Metric | March 2024 | March 2025 |
|---|---|---|
| Insider Ownership | Not Available | 3.09% |
| Institutional Ownership | 45.70% | 43.89% |
| Mutual Fund Ownership | 34.17% | 32.08% |
| 6-Month Share Buyback Ratio | Not Available | -3.64% |
The Cardlytics share buyback ratio indicates a net issuance of shares rather than buybacks over the six months leading up to March 2025. Additionally, the company faced a class-action lawsuit filed in February 2025, alleging misleading statements regarding growth projections. The lawsuit, coupled with the CEO's resignation and stock drops, may influence investor sentiment and potentially impact Cardlytics stock performance. For a deeper dive into the competitive environment, consider exploring the Competitors Landscape of Cardlytics.
Institutional and mutual fund ownership in Cardlytics decreased between March 2024 and March 2025, while insider ownership remained relatively stable. The company has experienced changes in leadership, and the share buyback ratio indicates net share issuance. These factors collectively shape the current Cardlytics ownership profile.
Cardlytics has engaged in equity financing, convertible senior notes offerings, and debt repurchases. These financial maneuvers aim to manage capital and debt. The company's financial actions also involved repurchase of its convertible senior notes, impacting its capital structure.
Cardlytics Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Cardlytics Company?
- What is Competitive Landscape of Cardlytics Company?
- What is Growth Strategy and Future Prospects of Cardlytics Company?
- How Does Cardlytics Company Work?
- What is Sales and Marketing Strategy of Cardlytics Company?
- What is Brief History of Cardlytics Company?
- What is Customer Demographics and Target Market of Cardlytics Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.